To understand and control complex tissues, the ability to genetically manipulate single cells is required. However, current delivery methods for the genetic engineering of single cells, including viral transduction, suffer from limitations that restrict their application. Here we present a protocol that describes a versatile technique that can be used for the targeted viral infection of single cells or small groups of cells in any tissue that is optically accessible. First, cells of interest are selected using optical microscopy. Second, a micropipette-loaded with magnetic nanoparticles to which viral particles are bound-is brought into proximity of the cell of interest, and a magnetic field is applied to guide the viral nanoparticles into cellular contact, leading to transduction. The protocol, exemplified here by stamping cultured neurons with adenoassociated viruses (AAVs), is completed in a few minutes and allows stable transgene expression within a few days, at success rates that approach 80%. We outline how this strategy is applied to single-cell infection in complex tissues, and is feasible both in organoids and in vivo.
Introduction
A central question in cell biology is how specific cellular and molecular processes underlie complex biological functions, such as how cells adapt to their environment, respond to stimuli, reproduce, metabolize and interact with other cells. To address these issues, it is crucial to be able to access and manipulate single cells, or small restricted groups of cells by regulating their gene expression. Recent techniques have enabled cell biologists to design and generate recombinant sequences of heritable genetic material 1, 2 . Introducing such DNA into eukaryotic cells allows either transient expression of exogenous genes or permanent modification of the genomes of affected cells, depending on the delivery method.
Moreover, the development of transgenic animal lines, human-derived organoids and genetic engineering methods, such as Cre-loxP and CRISPR, have greatly expanded our ability to target specific cells and tissues and study their development, function and diseases [3] [4] [5] [6] . As such, genetic engineering has reached a high level of sophistication, allowing region-specific, cell-type-specific and inducible genetic manipulations [7] [8] [9] [10] [11] [12] [13] . However, extensive genetic modifications across large groups of cells often activate compensatory mechanisms [14] [15] [16] , which can make it difficult to directly draw causal links between specific genes and organ function [17] [18] [19] . In addition, even within discrete regions of complex tissues, such as specific regions in the brain, individual cell types are frequently connected to proximal and distal cells in cell-type-specific ways 20, 21 . The need to understand such cellular individualities is easily overlooked in the approaches described above. To address limitations in current methods, we developed a simple, versatile and robust technique to mechanically target viruses to selected single or small groups of cells, thus allowing for their controlled genetic engineering 22 .
Development of the protocol
Using engineered viruses as vectors for the delivery of genetic material has emerged as a powerful tool in cell biology and gene therapy in the past several years 23, 24 . The vast array of existing viral vectors offers researchers cell-type-specific tropism and a variety of different expression time courses and stabilities 25 . However, tight spatial control of targeted transduction remains challenging and restricted to either a monolayer of cells or small groups of cells via virus dilution. To overcome such limitations, we have developed a technique termed virus stamping 22 (Fig. 1 ). Virus stamping delivers viruses to single cells through forced physical contact. Specifically, viruses are bound to magnetic nanoparticles using a generic attachment where the strength of the attachment between virus and magnetic nanoparticles is strong enough to keep them attached in solution, but weak enough for the virus to be released and infect its target cell when the virus-bound magnetic nanoparticle is brought into contact with its target cell 22 . The system is versatile, allowing different types of viruses to be used 22 . In our approach, optical microscopy is used to visualize and select the target cell(s). The virus-bound magnetic nanoparticles are then directed into physical contact with the selected cell(s) using magnetic forces ( Fig. 1) . Success rates of up to 80% and reliable single-cell specificity can be achieved using virus stamping in monolayered cells. Although the protocol detailed here describes procedures applied to cell culture, it can be extended for targeting single or small groups of cells embedded in tissues such as organoids and brains of live animals by integrating it with imaging methods such as shadow imaging using two-photon microscopy 22, 26, 27 .
Comparison with other methods
Previous approaches to target and genetically modify single cells include electroporation, electroporation followed by infection with pseudotyped viruses, atomic force microscopy (AFM) 28 and microfluidics. To alter gene expression, targeted single-cell electroporation or whole-cell patch clamp (using an intracellular solution that contains DNA plasmids) can be used 26, 29 . To further genetically modify a specific cell with viruses, targeted DNA transfection (outlined above) can be combined with pseudotyped viruses. For example, a target cell is first induced to express an exogenous receptor through targeted transfection and then exposed to a virus that recognizes the receptor. The avian tumor virus receptor A is commonly used for this purpose in mammalian systems, as it binds with high affinity and specificity to the envelope A glycoprotein of the avian sarcoma-leukosis virus; neither of which is normally present in mammalian cells 27, 29, 30 . A different approach, applicable only to cell culture, involves a cell infected with vaccinia virus attached to an AFM cantilever brought into contact with a single uninfected cell 31 or by using AFM cantilevers to deposit viruses onto cell surfaces 32 . Finally, push-pull microfluidics-based virus delivery has been used to infect individual neurons in culture by injecting rabies viruses onto the surface of targeted cells 33 . All of these approaches show limited applicability. For example, virus infection using AFM and push-pull microfluidics devices are restricted to monolayers of cells or tissue surfaces and are technically complex to perform because they require specialized equipment. Furthermore, single-cell electroporation techniques enable cells that are relatively deep in tissues to be targeted for genetic modification, but these techniques have a low efficiency (~2-10%), which has limited their adoption by the broader research community 34, 35 . is filled with a solution of virus-bound magnetic nanoparticles. Using a micromanipulator, the capillary is then moved to the target cell using optical guidance. Once the target cell is reached, the electromagnet is turned on and the pulsed electromagnetic field guides the virus-bound magnetic nanoparticles to the membrane of a target cell for infection. After 1 min, the magnet is turned off, the pipette is retracted, and the stamped area is monitored for gene expression. For more details see Supplementary Figure 1 .
Virus stamping has several advantages over existing techniques. First, the method allows transduction with nearly any virus type applied to almost any cell type. Second, virus stamping can be applied to modify cells in both monolayers and deep in tissue; the only limiting factor is the optics needed to guide the pipette to the selected cells. Third, virus stamping does not require chemical, physical or genetic pre-treatment of the targeted cells. Fourth, the method enables the co-transduction of multiple viruses to a selected cell or small group of cells. Fifth, the number of transduced cells and the spatial arrangement in which they are transduced can be controlled through magnetic guidance. The advantages of the virus-stamping approach permit a wide range of applications related to guiding and elucidating the function of selected single cells and groups of cells both in vitro and in vivo. We believe that virus stamping may find use in diverse areas of applied and basic biology.
A considerable advantage of virus stamping is that the stamping approach and optical microscopy needed to guide the stamping process can be specifically tailored based on the biological question of interest. For example, a researcher who seeks to determine the labeling of a single cell with a fluorophore on a monolayer of cultured cells can do this with basic wide-field imaging techniques to guide the pipette to a selected cell and stamp it. A researcher capable of imaging deep in tissue (for example, using confocal or two-photon microscopy) and obtaining activity measurements (for example, using time-lapse microscopy and genetically encoded calcium sensors), can select and target single or small groups of cells in complex tissues and animals and simultaneously extract detailed information on the state of the cells.
Limitations
The protocol detailed here describes the targeted transduction of cells with AAVs. Most of the materials and reagents used for virus stamping are readily available to most cell biology laboratories and we provide a detailed list of vendors and product numbers below. Virus stamping can face distinct problems, which include the need for magnets customized to fit the spatial limitations of the experimental setup and to generate sufficiently high magnetic fields (~120 mT), which may interfere with the experimental setup used. In addition, the depth at which cells are targeted with virus stamping is limited by the feasibility of visually guiding the pipette to a target cell 36 .
Virus stamping was developed for targeting single cells in vitro and in vivo 22 . However, there are several applications in biology and biomedical sciences, such as virology, immunology, cancer biology and gene therapy, where multiple cells in localized areas need to be stamped and followed over time. In its current form, virus stamping is limited to stamping at a relatively slow rate of~3 cells iñ 15 min. However, by reconfiguring some parameters virus stamping can be readily modified to stamp multiple cells, although in a slightly less targeted manner, in a given spatial region both in vitro and in vivo 22 .
Although we demonstrated that the virus-stamping method could also be applied to stamp various kinds of viruses 22 , there are two limitations to note. First, the reversible attachment of the virus to the magnetic nanoparticle is an electrostatic interaction where viruses that are typically negatively charged bind through electrostatic attachment to the positively charged nanoparticles. However, in some cases viruses are positively charged, such as variants of the herpes simplex virus 37 , and the nanoparticles may have to be charged negatively to facilitate attachment of the virus. Second, the viruses tested in our original article 22 , including AAVs or rabies viruses, are relatively small (diameter ≤ 180 nm). So far, we have not tested the virus-stamping approach for much larger viruses, such as the megavirus (diameter > 300 nm), or viruses that have very different shapes and surface properties, such as bacteriophages.
Applications of the method
Virus stamping provides a robust and reproducible gene delivery method for studying and controlling cells both in vitro and in vivo. For instance, virus stamping has previously been used to (i) simultaneously infect single cells with multiple viruses, with each virus driving expression of a different gene; (ii) drive expression of the calcium indicator GCaMP6s in target cells, followed by subsequent two-photon calcium imaging of neuronal activity in vivo; and (iii) perform single-cell-initiated rabiesmediated transsynaptic circuit tracing 22 . Virus stamping may also be used to study virus delivery and entry mechanisms, similar to what has recently been done using an AFM-based approaches 38 . For example, virus stamping of neurons could be used to characterize the binding and entry of the rabies virus at different locations of the neuron, such as at the dendrites, soma and axon 39 .
In addition, it is possible to combine virus stamping with channelrhodopsin-assisted patching 36 to allow for targeting of cells in deep tissue where optical access becomes a limitation. We envision that repetitive stamping of the same cell with different viruses could be used to address limited viral packaging sizes and thus reduce restrictions of the size of gene that can be delivered. For example, the packaging size restriction of a single virus can be overcome by splitting the viral payload over several vectors, which could be delivered either simultaneously in a single stamping session or during subsequent stamping sessions. Finally, although virus stamping was initially designed to infect only single cells, such as described in this protocol, we have shown in our original paper 22 that stamping can also be used to infect multiple cells in a localized area by a more widespread (and less targeted) injection of virus-bound magnetic nanoparticles.
Experimental design

Protocol purpose and description
The primary use of this protocol is to enable researchers to guide viruses for the targeted infection of single or small groups of cells ( Fig. 2) . We describe the virus-stamping approach in which the user guides a patch pipette containing virus-bound magnetic nanoparticles into proximity of a targeted cell in culture and directs the nanoparticles using an electromagnetic field into contact with the cell. We demonstrate the approach on cultured rat cortical neurons. Although the protocol utilizes AAVs for infecting cortical neurons, it also works with a diverse set of viruses (including rabies, lentiviruses and herpes simplex viruses as demonstrated in our original manuscript 22 ) and a diverse array of cell and tissue types (including HeLa and HEK-293T cell lines, mouse retina and cortex, and brain organoids derived from human pluripotent stem cells) 22 .
Choice of viruses
Our stamping approach delivers virus-bound magnetic nanoparticles to the cell surface. In the case of neurons, infection of the cell body can be achieved by using a virus that preferentially infects the soma (that is, AAV and influenza) 40, 41 or by pseudotyping viruses with a glycoprotein that endows the ability to preferentially infect the soma, such as the vesicular stomatitis virus envelope glycoprotein 42 .
Here we used an AAV serotype 1 (AAV2/1) that encodes enhanced green fluorescent protein (eGFP) (see 'Materials' section). Depending on the cell type and tissue to be stamped, whether the goal is for the virally encoded gene to be inserted into the host cell genome or not, and whether the goal is for the virus to stay within the target cell or jump transsynaptically, the specific virus and viral coat selected for stamping need to be carefully considered 43, 44 .
Choice of magnetic nanoparticles
An important criterion to consider in stamping is the volume of the magnetite in the nanoparticle. The larger the quantity of magnetite, the better the mobility that the nanoparticle exhibits when exposed to a given magnetic field. However, larger-sized nanoparticles increase the chances of clogging the pipette tip. On the basis of our original study, we suggest using nanoparticles ≤200 nm in diameter. In the current protocol, we used nanoparticles from OZ Bioscience (ViroMag) with diameters ranging from 50 to 200 nm.
Attaching viruses to magnetic nanoparticles
The successful attachment of viruses to nanoparticles depends on two properties. First, the purity of the virus has a substantial role. If the virus sample contains a high background of proteins (or other macromolecules) left over from purification, or viruses have disassembled during storage, these smaller macromolecules nonspecifically adsorb to the nanoparticles and interfere with the attachment of competent viruses. Thus, it is of high importance to have a clean, background-free virus sample and to store the sample under conditions that limit virus deterioration 45 (Fig. 3 ). Second, it is important to adjust the ratio of nanoparticles and viruses. On the basis of the results from our original paper 22 , direct conjugation of viruses and nanoparticles can be achieved with set ratios of 1 μl virus solution with a titer of 1 × 10 11 to 1 × 10 13 genome copies (GC) ml -1 to 10 μl magnetic nanoparticle solution (~0.1 mg ml -1 ) 46 . However, this ratio depends on the virus that is used, as different viruses have different surface proteins, shapes, surface charges and sizes that affect their binding to the spherical magnetic nanoparticle. For example, in our original paper, we used titers of~1 × 10 6 GC ml -1 of rabies viruses 22 .
Choice of cell type and tissue
Virus stamping has been used in cell culture, mouse retina, brain slices, brain organoids and the cortex of live mice 22 . It is advisable to choose an area that is accessible for optical imaging to precisely guide the stamping pipette to the selected cells. For simplicity in describing the stamping protocol, here we apply virus stamping to cultures of neurons.
Cell culture chamber
We and others have observed that cellular systems change their uptake and expression of viruses depending on the environmental conditions 38, 47 . Thus, to ensure that cells are transduced with viruses in appropriate conditions, the experiments should be done in a cell culture chamber that allows for simultaneous optical imaging and micropipette manipulation 31, 38 ( Supplementary  Figure 1 ). The chamber should control temperature, humidity, gas and buffer solution. Step 14
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Choice of glass capillaries for pulling patch pipettes
We used capillaries made of borosilicate glass, which we pulled to obtain patch pipettes with inner diameters of~1-3 μm ( Fig. 4 ). We note that this range of inner diameters correlates with pipette resistances of~1-5 MΩ. The choice of borosilicate and 1-3-μm inner diameters were to keep the pipettes compatible with the existing pipette pullers, optical imaging techniques and nanoparticle diameters of~50-200 nm. Inner diameters of >3 μm often lead to the leaking of virus-bound magnetic nanoparticles, which can cause undesired off-target transduction.
Loading virus-bound nanoparticles into glass capillaries
For targeting cells on a monolayer, virus-bound nanoparticles are directly loaded into the tip of the pipette (Fig. 5 ). This approach is used in this protocol. However, for targeting cells in tissues using shadow imaging (see 'Targeting cells for virus stamping using optical imaging' section), virus-bound nanoparticles may be filled from the back of the pipette containing PBS.
Targeting cells for virus stamping using optical imaging Cells are optically targeted for stamping within a monolayer of cells or in a tissue. Wide-field imaging techniques such as differential interference contrast (DIC) microscopy or fluorescence microscopy can be used to guide the pipette loaded with virus-bound nanoparticles to cells in a monolayer 22, [48] [49] [50] .
To guide the pipette to single cells embedded in deeper layers of tissue, two-photon microscopy-based shadow imaging can be used. Shadow imaging is a method in which the extracellular space is labeled using a membrane-impermeable dye expelled from the pipette, thereby creating a negative 'shadow' of the cell soma 22, 27, 51 .
Pull down of virus-bound magnetic nanoparticles
In our setup, magnetic pulses with a strength of 120-mT at a frequency of 1 Hz for 0.5 min were effective in pulling down the nanoparticles to the tip of the pipette. However, for each experimental setup, the pull-down parameters should be optimized by adjusting the amplitude and number of magnetic pulses. The pull-down rate of the magnetic field, which has been optimized for inner diameters of the pipette tip of~1-3 μm, can be measured by monitoring the mobility of the beads using fluorescence microscopy ( Supplementary Video 1) .
Stamping of multiple cells on a monolayer
Virus stamping can be used to sequentially stamp up to three cells with the same pipette withiñ 10-15 min. When targeting multiple cells, it is essential to minimize vertical pipette movements to avoid loaded beads at the open pipette end from infecting non-targeted cells. In our experiments, we avoided repeatedly moving the pipette up and down by ≫200 μm. To stamp more than three cells, one may need to use more than one pipette, as multiple cycles of applying a strong magnetic field can cause the magnetic nanoparticles to clog the pipette (Fig. 5 ). However, in vivo, such serial stamping is not possible using the shadow imaging approach, which expels a solution from the pipette tip before finding the target cell 22 .
Assessing the success of virus stamping If the virus encodes a fluorophore, the success of virus stamping can be evaluated using time-lapse optical microscopy by monitoring the expression of a fluorescent reporter. Imaging may be repeated multiple times to provide time-series data and to monitor changes in neuronal morphology or gene expression 52, 53 .
Materials
Biological materials
• Primary rat cortex neurons (Thermo Fisher Scientific, cat. no. A1084002) ! CAUTION Cell lines eventually used in your research should be regularly checked to ensure that they are not infected with mycoplasma. • AAV virus serotype 1 (AAV2/1) encoding eGFP, titer 1 × 10 13 GC ml -1 (VectorBiolabs, cat. no. 7002)
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• Cell culture chamber: we used an in-house-developed cell culture chamber to maintain cells in incubator-like conditions by controlling the temperature (37°C), CO 2 concentration (5% CO 2 in synthetic air) and humidity (relative humidity >95%) 31 
Reagent setup
Primary neuron culture medium Add 10% (vol/vol) horse serum, 0.5 mM glutamax, 1 mM sodium pyruvate and 2% (vol/vol) B-27 to 500 ml of neurobasal medium. Maximum storage time of 1 month at 4°C. Pipette solution PBS is used as pipette solution. Maximum storage time for PBS is 14 d at 25°C.
Poly-D-lysine hydrobromide
Electromagnet setup
Take a Gaussmeter and measure the magnetic field of the electromagnet at the bottom of the Petri dish. The magnetic field should be adjustable and reach at least 120 mT at the pipette tip. Ensure that NATURE PROTOCOLS PROTOCOL the magnet is aligned parallel to the pipette tip and that the maximum strength of the magnetic field is reached at the pipette tip. Note that the strength and gradient of the magnetic field depend on the geometry of the magnet and should be measured with the Gaussmeter ! CAUTION Remember to turn the electromagnet off after use. Electromagnets left on for prolonged periods can become extremely hot, short circuit and catch fire.
Quality control of virus
Thaw the virus shortly before usage and keep at 4°C. Depending on the virus type, we recommend keeping the maximum storage type for a virus below 1 month at 4°C. Verify whether your viruses can infect cells robustly. In this protocol, we use AAVs encoding eGFP. Verify infectivity of AAVs by injecting 1 μl of virus in a 35-mm diameter Petri dish with a confluent layer of~1 × 10 6 cortical neurons. Wait for >24 h after the infection to monitor eGFP expression and the number of cells infected. Suitable virus preparations should infect >80% of the cells ! CAUTION Note, local gene regulatory and biosafety laws must be followed for each virus type used. For our laboratory, the engineered AAVs have been classified as biosafety level 1 on the basis of the regulations enforced in Switzerland. However, when handling biohazardous material, follow higher biosafety levels if necessary. When switching to other viruses please follow the biosafety rules and regulations of the appropriate institute and country regarding experimental handling.
Quality control of glass pipettes
Visually check your pipette tip with the 20× objective with DIC imaging to approximate the bore diameter opening and to ensure that the tip is not clogged. Maximum storage time for freshly pulled pipettes is 6 h at room temperature (23°C). Pull fresh pipettes if the storage time exceeds 6 h.
Procedure
Preparing virus-bound magnetic nanoparticles • Timing~13 h 1 Vortex and resuspend 100 μl of diluted stock solution (0.1 mg ml -1 ) of magnetic nanoparticles in 1 ml of fresh sterile-filtered PBS in a 1.5-ml microcentrifuge tube. 2 Sonicate resuspended magnetic nanoparticles from Step 1 for 30 min at 35 kHz and 37°C. 3 Add 10 μl of AAV virus suspension of titers ranging from 1 × 10 11 to 1 × 10 13 GC ml -1 to resuspended magnetic nanoparticles. 4 Mix the solution containing the virus-bound magnetic nanoparticles by pipetting up and down five times using a 1-ml pipette. 5 Leave the mixture on the Biomixer at 24 r.p.m. for 12 h at 20-27°C. 6 Take the tube off the Biomixer and attach a neodium boron permanent magnet to the side of the tube using a double-sided tape and leave in this configuration for ≥10 min. This procedure will trap the virus-bound magnetic nanoparticles to the side of the microcentrifuge tube. 7 Keep the magnet against a 1.5-ml tube, aspirate out the supernatant using a 1-ml pipette and resuspend in 1 ml of PBS. Repeat this cycle three times to ensure that the unbound virus is washed off. ! CAUTION Monitor the pipette approach to avoid aspirating out magnetic nanoparticles. To avoid this, tilt the 1.5-ml tube to the side and aspirate gently. 8 Aspirate the supernatant, take the magnet off and resuspend the nanoparticles in 1 ml of fresh sterile-filtered PBS. 9 Remove aggregated virus-bound nanoparticles, using either a NAP-5 desalting column (option A) or a syringe filter (option B). We suggest first applying option A; if this is insufficient, apply option B. c CRITICAL STEP The virus should not be resuspended in a Tris-containing buffer commonly used to store virus stocks, as during functionalization the Tris will react with the aldehyde groups of the nanoparticles. j PAUSE POINT Virus-bound magnetic nanoparticles should not be frozen but rather stored at 4°C. Maximum storage time for virus-bound magnetic nanoparticles is 6 h at 4°C. 10 In parallel to the rest of the procedure (Steps 11-24), you can assess the quality of the virus-bound nanoparticle preparation by injecting 1 µl of virus-bound magnetic nanoparticles from Step 9 into a 35-mm diameter Petri dish plated with a confluent layer of~1 × 10 6 cells. Wait for 24 h and assess infectivity by monitoring the gene expression of eGFP (in case of using eGFP-encoding viruses). A good virus preparation should have infected >80% of the cells. c CRITICAL STEP This step allows you to see whether the cells are infected by the virus-bound beads. It allows you to evaluate the outcome of Steps 11-23. If Steps 11-23 failed, but Step 10 was successful, the nanoparticles were infective, but stamping did not work. So the mistake may be identified in Steps 11-23 ? TROUBLESHOOTING
Calibrating the cell culture chamber • Timing~15 min 11 Turn on the temperature control of the chamber to 37°C. Switch on the microscope and microscope controlling software. 12 Set up a <95% relative humidity atmosphere and 5% CO 2 . 13 Culture neurons for 2-3 d before the experiment in a 35-mm diameter Petri dish. Place the dish on the microscope dish holder.
Pulling glass pipettes • Timing~5 min 14 Pull patch pipettes from glass capillaries for achieving opening (bore) diameters of 1-3 μm. We observed that capillaries with openings of these diameters have resistances between 1 and 5 MΩ. j PAUSE POINT Pulled patch pipettes can be stored for 6 h at room temperature in Petri dishes in air.
Calibrating the magnet for nanoparticle pullout • Timing~15 min 15 Calibrate the power settings of the magnet to ensure 120 mT at the bottom of the Petri dish. Take a Gaussmeter and place it at the point where you expect the cells to be targeted by virus-bound magnetic nanoparticles. Measure the magnetic field from the electromagnet. Ensure that the strength of the magnetic field is at least 120 mT. If this is not the case adjust the position of the magnet to optimize the magnetic field strength at the selected point. 16 Place the Petri dish from Step 13 in the calibrated chamber. 17 Load the pipette carefully with~1-10 μl of solution containing the virus-bound magnetic nanoparticles (from Step 9) using a microloader pipette tip, similar to loading a pipette with solution for patch-clamp recordings. Attach the loaded pipette to the micromanipulator and guide the tip of the pipette to~100 μm above a monolayer of cells using the micromanipulator. Monitor the approach of the pipette using brightfield imaging. ! CAUTION Avoid air bubbles while loading the pipette with virus-bound nanoparticles. 18 Turn the electromagnet on at appropriately calibrated power settings (Step 15) for~1 min.
? TROUBLESHOOTING 19 Assess the pullout of virus-bound nanoparticles by optically monitoring the pullout of fluorescently labeled virus-bound magnetic nanoparticles (Supplementary Video 1) or by monitoring transgene expression after 24 h using fluorescence microscopy ( Fig. 4) (Step 25) .
Optical-imaging-assisted stamping • Timing~15 min 20 Approach the pipette to the cell of interest using the micromanipulator guided by optical microscopy (Supplementary Video 2) . Cells of interest may be selected using transgenic markers or using brightfield microscopy (for example, phase contrast or DIC) for targeting unlabeled cells. 21 For stamping single cells, once the pipette is gently brought as close as possible above the target cell (micrometer range) without touching the cell membrane, turn the electromagnet on and apply 120 mT pulses of~0.5-min duration at a frequency of~1 Hz. ! CAUTION Do not attempt to patch the cell. 22 Retract the pipette and proceed to optically access gene expression of a stamped cell (Step 25) .
! CAUTION Monitor the pipette approach under visual control to avoid damaging cell.
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PROTOCOL 23 The same pipette can be used to stamp multiple cells sequentially. To do so, repeat Steps 20-22 and use the on/off switch of the electromagnet (Fig. 5c ). Note, virally encoded fluorescent reporters generally take at least 24 h to be expressed to a level at which they can be detected. ! CAUTION If intending to stamp more than one cell, do not retract the pipette past the liquid interface.
? TROUBLESHOOTING
Assessing the gene expression • Timing~24-48 h 24 Assess expression of the gene of interest using time-lapse fluorescence microscopy in the cell culture chamber or simply by monitoring transgene expression after 24 h using fluorescence microscopy (Fig. 4) .
Troubleshooting
Troubleshooting advice can be found in Table 1 .
Timing
Steps To check the quality of virus production, we used negative-stain TEM. 5 μl of virus sample was pipetted onto a glow-discharged copper grid coated with parlodion and carbon, and left to absorb for 1 min. The grid was then washed with four droplets of ultrapure water and subsequently stained with 2% uranyl acetate for 10 s, blotting between each step. Grids were imaged using a TEM-T12 microscope equipped with LaB6 filament operated at 120 kV The wash of the virus-bound magnetic nanoparticleswas too strong Wash and resuspend gently in Step 8 by aspirating and resuspending virusbound nanoparticles in PBS drop by drop. Another source of error for this is the filtering of virus-bound nanoparticles, which could disrupt attachment of the virus to nanoparticles. Instead of filtering, one could use desalting columns to collect fractions of virus-bound magnetic nanoparticles (Step 9). This is because large aggregates of virus-bound magnetic nanoparticles will elute faster than free nanoparticles Nanoparticles aggregated, resulting in insufficient attachment of viruses to nanoparticles NHS chemistry can be used to chemically bind viruses to nanoparticles 54 Solution 4: TEM image the solution containing the magnetic nanoparticles and assess the aggregation state. If large aggregates are seen, proceed to sonicate again for 1 h at 35 kHz and 37°C 18 No cells were infected from pullout
Pipette capillary clogged with virus-bound magnetic nanoparticles
Ensure that the opening diameters of the pulled pipettes were in the range of~1-3 μm. To approximate the pipette opening diameter, measure the resistance of the pipette, or use light microscopy or scanning electron microscopy. If the pipette opening is~1-3 μm, label magnetic nanoparticles with fluorophores 55 . We recommend using an NHS ester conjugated to an Alexa dye. Load fluorescent magnetic nanoparticles in a pipette and monitor the mobility of nanoparticles using optical microscopy by acquiring optical time-lapse images while applying a pulse magnetic field at 120 mT using 10-s intervals of on and off cycles. Analyze the video to assess the mobility of the magnetic nanoparticles (Supplementary Video 1) 23
More than one cell infected Pipette not close enough to the cell Ensure that the pipette is as close as possible to the cell (micrometer range) without touching the cell membrane when stamping. Ideally, using DIC microscopy to locate pipette on cell
Anticipated results
Under optimized conditions, an experienced experimenter can stamp between one and three visually selected cells in a single session with one pipette, with an~80% success rate per cell. Specifically, in the current protocol, we tested this on a sample size of 11 independent experiments and achieved 8 successful stamps for pipette opening diameters of~1-3 μm and 9 successful stamps for opening diameters of >3 μm. However, these values are given for cultured neurons and depend on the virus, cell type, and cell culture or tissue. On average, stamping a single neuron with virus-bound magnetic nanoparticles took~1-5 min to perform (Supplementary Video 2) . The stamped neurons can subsequently be imaged and also targeted for activity recordings. Stamped neurons are viable and display normal activity 22 , and stable transgene expression can be observed weeks after stamping using AAVbound magnetic nanoparticles. In Fig. 5 , we demonstrate co-transduction for mRuby and GCaMP6s in single neurons. In principle, this can be extended to other applications beyond co-transduction of fluorophores. For example, for gene-editing applications one can attach one vector encoding Cas9 nuclease and another vector encoding the guide RNA. Previously, we confirmed that the virusstamping procedure allows neurons to remain healthy by stamping a small population of neurons in vivo with AAV viruses encoding GCaMP6s and recording GCaMP6s-based activity for accessing their health 22 . Next, we extend the stamping approach to multiple cells and show that it can be used also for targeted expression of tdTomato in a small population of defined neurons. Lastly, although this protocol describes procedures for stamping cultured neurons with AAV viruses, the stamping technique can be extended to deep tissue and live animal applications, as we have previously shown 22 .
Reporting Summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article. 
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
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Data collection
All fluorescence microscopy images were collected either using the Leica Application Suite X ( LAS X) or Nikon NDS software. Transmission electron microscopy (TEM) images were recorded using a commercially avaiable TEM (Philips CM100 including the TEM software). Scanning electr microscopy (SEM) images were recording using a commercially available SEM (Zeiss Supra 50 VP including the SEM software).
Data analysis
All images and videos were rendered using IMARIS version 9.2 software (www.bitplane.com). The experimental data was plotted using GraphPad Prism Pro (www.graphpad.com).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
